Literature DB >> 3686635

Heterogeneity in the responses of clones of Giardia intestinalis to anti-giardial drugs.

P F Boreham1, R E Phillips, R W Shepherd.   

Abstract

Clones of two stocks of Giardia intestinalis have been tested by the [3H]thymidine uptake assay to determine their sensitivity to metronidazole, tinidazole, furazolidone and quinacrine. Each stock was not homogeneous with respect to drug sensitivity but was composed of different populations of organisms. Doubling times of lines derived from clones of a stock did not vary significantly. These findings may, in part, account for treatment failures in human giardiasis patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3686635     DOI: 10.1016/0035-9203(87)90151-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  6 in total

Review 1.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

2.  Comparison of an in vitro method and an in vivo method of Giardia excystation.

Authors:  J L Isaac-Renton; H Shahriari; W R Bowie
Journal:  Appl Environ Microbiol       Date:  1992-05       Impact factor: 4.792

3.  Comparison of Giardia isolates from different laboratories by isoenzyme analysis and recombinant DNA probes.

Authors:  W L Homan; F H van Enckevort; L Limper; G J van Eys; G J Schoone; W Kasprzak; A C Majewska; F van Knapen
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

4.  Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. in vitro.

Authors:  U M Morgan; J A Reynoldson; R C Thompson
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

Review 5.  The biology of Giardia spp.

Authors:  R D Adam
Journal:  Microbiol Rev       Date:  1991-12

6.  Allelic sequence heterozygosity in single Giardia parasites.

Authors:  Johan Ankarklev; Staffan G Svärd; Marianne Lebbad
Journal:  BMC Microbiol       Date:  2012-05-03       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.